BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25070656)

  • 1. From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo.
    Luyeye Mvila G; Postema S; Marchal G; Van Limbergen E; Verdonck F; Matthijs G; Devriendt K; Michils G; Van Ongeval C
    BMC Public Health; 2014 Jul; 14():759. PubMed ID: 25070656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
    Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
    JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ability to Look: Management of Breast Disease in the Democratic Republic of the Congo Using Smart Ultrasound Technology.
    Henry-Tillman R; Kabongo M; Laryea J; Pinder L; Bittenbinder R; Osgood G; Hicks M; Hicks M; Parham G
    J Am Coll Surg; 2021 Apr; 232(4):636-640. PubMed ID: 33348015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
    Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
    Murakami W; Tozaki M; Nakamura S; Ide Y; Inuzuka M; Hirota Y; Murakami K; Takahama N; Ohgiya Y; Gokan T
    Breast Cancer; 2019 Sep; 26(5):552-561. PubMed ID: 30820924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI in the early detection of breast cancer in women with high genetic risk.
    Trecate G; Vergnaghi D; Manoukian S; Bergonzi S; Scaperrotta G; Marchesini M; Ferranti C; Peissel B; Spatti G; Bohm S; Conti A; Costa C; Sporeni M; Podo F; Musumeci R
    Tumori; 2006; 92(6):517-23. PubMed ID: 17260493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge regarding breast cancer among Congolese women in Kinshasa, Democratic Republic of the Congo.
    Sulu SMM; Mukuku O; Sulu AMS; Massamba BL; Mashinda DK; Tshimpi AW
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1758. PubMed ID: 36404296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast self-examination also valuable in women participating in a screening programme].
    Zonderhuis BM; Meijer S; Been J; Groot JJ; Langenhorst F; van den Tol MP
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2341-5. PubMed ID: 19024066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
    Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C
    Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mammographic screening with the assessment of risk factors and incidence of BRCA-associated breast cancer in the Republic of India].
    Ternovoĭ SK; Matkhev S; Meladze NV; Solopova AE; Abduraimov AB; Les'ko KA
    Vestn Rentgenol Radiol; 2012; (5):16-21. PubMed ID: 23516880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of risk factors and early detection methods toward breast cancer among healthcare workers in Kinshasa, Democratic Republic of the Congo.
    Sulu SMM; Mukuku O; Sulu AMS; Massamba BL; Wembonyama SO
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2067. PubMed ID: 38600420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.
    Shah P; Rosen M; Stopfer J; Siegfried J; Kaltman R; Mason B; Armstrong K; Nathanson KL; Schnall M; Domchek SM
    Breast Cancer Res Treat; 2009 Dec; 118(3):539-46. PubMed ID: 19609668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.
    Carmichael H; Matsen C; Freer P; Kohlmann W; Stein M; Buys SS; Colonna S
    Breast Cancer Res Treat; 2017 Apr; 162(2):225-230. PubMed ID: 28138892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Knowledge of women and men about breast cancer prevention].
    Najdyhor E; Krajewska-Kułak E; Krajewska-Ferishah K
    Ginekol Pol; 2013 Feb; 84(2):116-25. PubMed ID: 23668058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
    Cott Chubiz JE; Lee JM; Gilmore ME; Kong CY; Lowry KP; Halpern EF; McMahon PM; Ryan PD; Gazelle GS
    Cancer; 2013 Mar; 119(6):1266-76. PubMed ID: 23184400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.